Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
Measuring quality of care in the anti neutrophil cytoplasm antibody (ANCA) associated vasculitides (AAV) has become more complex, because the introduction of immunosuppressive therapy has resulted in a substantial improvement in survival. Early diagnosis remains a problem, because many patients are...
Main Authors: | Mukhtyar, C, Luqmani, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Using the Birmingham vasculitis activity score (BVAS) to screen for vasculitis
by: Mukhtyar, C, et al.
Published: (2008) -
Eular recommendations for vasculitis
by: Luqmani, R, et al.
Published: (2007) -
Cardiovascular outcomes in ANCA associated vasculitis
by: Mukhtyar, C, et al.
Published: (2008) -
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
by: Mukhtyar, C, et al.
Published: (2007) -
Cardiovascular involvement in primary systemic vasculitis.
by: Mukhtyar, C, et al.
Published: (2009)